Nom du produit:(1S,3S,4R)-2-tert-butoxycarbonyl-5-methylene-2-azabicyclo[2.2.2]octane-3-carboxylic acid
IUPAC Name:(1S,3S,4R)-2-[(tert-butoxy)carbonyl]-5-methylidene-2-azabicyclo[2.2.2]octane-3-carboxylic acid
- CAS：2410984-39-1
- Formule moléculaire：C14H21NO4
- Pureté：95%+
- Numéro de catalogue：CM1044006
- Poids moléculaire：267.33
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2410984-39-1
- Formule moléculaire:C14H21NO4
- Point de fusion:-
- Code SMILES:OC(=O)[C@@H]1[C@@H]2CC[C@H](N1C(=O)OC(C)(C)C)CC2=C
- Densité:
- Numéro de catalogue:CM1044006
- Poids moléculaire:267.33
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Piperidines
- Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
- Piperidine,Piperidine Price
- if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Column Infos
- DSP-5336
- Sumitomo Pharma announces that DSP-5336 has received FDA Fast Track Designation for the treatment of relapsed or refractory acute myeloid leukemia (AML) with a KMT2A rearrangement, also known as, mixed lineage leukemia rearrangement (MLLr) or nucleophosmin mutation (NPM1m). Menin serves as a tumor suppressor in endocrine glands. Novel menin inhibitors are novel targeted agents in clinical studies targeting genetically defined subsets of acute leukemia.
DSP-5336 is an investigational menin-MLL interaction inhibitor. DSP-5336 has been granted Orphan Drug Designation in acute myeloid leukemia, and Fast Track Designation in relapsed or refractory acute myeloid leukemia with MLLr or NPM1m.
Recherche 
+86 21 5895 0110 
